These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8743003)

  • 21. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients.
    Harris A; Arend O; Chung HS; Kagemann L; Cantor L; Martin B
    Ophthalmology; 2000 Mar; 107(3):430-4. PubMed ID: 10711877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.
    Strahlman E; Tipping R; Vogel R
    Am J Ophthalmol; 1996 Aug; 122(2):183-94. PubMed ID: 8694086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
    Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
    J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypotensive efficacy of dorzolamide HCL-timolol maleate 0.50% vs concomitant use of the two drugs.
    Durante A; Aurilia P; Guarnaccia G; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):46. PubMed ID: 11235533
    [No Abstract]   [Full Text] [Related]  

  • 28. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
    Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D; Maloney S; Vaccarelli L; Liss C; Wilson H; Gormley GJ
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
    Shin D
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.
    Konstas AG; Maltezos A; Bufidis T; Hudgins AG; Stewart WC
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA; Wilde MI
    Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.
    Centofanti M; Manni G; Gregori D; Cocco F; Lorenzano D; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):302-5. PubMed ID: 10853928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
    Hommer A; Kapik B; Shams N;
    Br J Ophthalmol; 2003 May; 87(5):592-8. PubMed ID: 12714402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
    Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
    Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.